RhumbLine Advisers
SRRA

RhumbLine Advisers’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

RhumbLine Advisers’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-19,058
Closed -$1.05M – 3106
2022
Q2 		$1.05M Buy
+19,058
New +$1M ﹤0.01% 2117

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

RhumbLine Advisers's SRRA Position: Q3 2022 in Review

RhumbLine Advisers sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 19,058 shares — an estimated $1.05M sold.

RhumbLine Advisers first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $1.05M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • RhumbLine Advisers reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • RhumbLine Advisers sold 19,058 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $1.05M.
  • RhumbLine Advisers first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • RhumbLine Advisers's Sierra Oncology, Inc. Common Stock position peaked at $1.05M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on RhumbLine Advisers's 13F filing for Q3 2022, filed 10 Nov 2022.